Research Progress in Immunotherapy of NSCLC With EGFR-Sensitive Mutations.
Yang Y, Zhang X, Gao Y, Dong Y, Wang D, Huang Y, Qu T, Fan B, Li Q, Zhang C, Cui X, Zhang B.
Yang Y, et al. Among authors: huang y.
Oncol Res. 2022 May 4;29(1):63-74. doi: 10.3727/096504022X16462176651719. Epub 2022 Mar 2.
Oncol Res. 2022.
PMID: 35236543
Free PMC article.